in controlled comparative trials , most of which were doubly blinded , oral ciprofloxacin was equal in terms of safety and therapeutically equal or superior to oral trimethoprim-sulfamethoxazole in urinary and gastrointestinal infections , to oral ampicillin in respiratory infections , and to parenteral cefotaxime in skin and soft tissue disease .
C0002680
ampicillin
C0035243
respiratory infections